- Home
- ORKA vs APPS Comparison
ORKA vs APPS Comparison
Compare ORKA & APPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- APPS
- Stock Information
- Founded
- ORKA 2004
- APPS N/A
- Country
- ORKA United States
- APPS United States
- Employees
- ORKA N/A
- APPS N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- APPS Multi-Sector Companies
- Sector
- ORKA Health Care
- APPS Miscellaneous
- Exchange
- ORKA Nasdaq
- APPS Nasdaq
- Market Cap
- ORKA 580.3M
- APPS 562.7M
- IPO Year
- ORKA N/A
- APPS N/A
- Fundamental
- Price
- ORKA $15.44
- APPS $4.23
- Analyst Decision
- ORKA Strong Buy
- APPS Buy
- Analyst Count
- ORKA 9
- APPS 3
- Target Price
- ORKA $40.38
- APPS $4.83
- AVG Volume (30 Days)
- ORKA 142.1K
- APPS 4.3M
- Earning Date
- ORKA 08-11-2025
- APPS 08-05-2025
- Dividend Yield
- ORKA N/A
- APPS N/A
- EPS Growth
- ORKA N/A
- APPS N/A
- EPS
- ORKA N/A
- APPS N/A
- Revenue
- ORKA N/A
- APPS $503,443,000.00
- Revenue This Year
- ORKA N/A
- APPS $8.47
- Revenue Next Year
- ORKA N/A
- APPS $8.74
- P/E Ratio
- ORKA N/A
- APPS N/A
- Revenue Growth
- ORKA N/A
- APPS N/A
- 52 Week Low
- ORKA $5.49
- APPS $1.18
- 52 Week High
- ORKA $52.32
- APPS $7.77
- Technical
- Relative Strength Index (RSI)
- ORKA 59.14
- APPS 41.73
- Support Level
- ORKA $14.10
- APPS $3.78
- Resistance Level
- ORKA $15.76
- APPS $4.38
- Average True Range (ATR)
- ORKA 1.12
- APPS 0.27
- MACD
- ORKA 0.04
- APPS -0.05
- Stochastic Oscillator
- ORKA 83.71
- APPS 22.61
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About APPS Digital Turbine Inc.
Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.